Guggenheim maintained a Buy rating on Merck (NYSE:MRK) shares but reduced the price target to $115 from $122. The adjustment follows a comprehensive review of the pharmaceutical giant's fourth-quarter ...

Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

The Walt Disney Co. announced Thursday, May 18 ... That included an arrangement with a law firm that's sued Merck over Gardasil, its human papillomavirus vaccine that prevents cervical cancer. The ...

(RTTNews) - Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP recommended the approval of CAPVAXIVE ...

It’s National Hot Chocolate Day – a day to celebrate the chocolaty, creamy goodness in mug. The Cosy Tea Room in Winsford topped the table when it came to finding out who serves the best afternoon ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday. Terence Flynn has given his Hold rating due to a combination of factors ...

The lawsuit alleges marketing fraud against pharmaceutical company Merck for its HPV vaccine, Gardasil, which Merck denies. The Centers for Disease Control and Prevention (CDC) maintains that the ...

Shares of this pharmaceutical company have returned -1.2% over the past month versus the Zacks S&P 500 composite's +1.2% change. The Zacks Large Cap Pharmaceuticals industry, to which Merck ...

Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 12 unusual trades. Delving into the details, we found 33% of ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best blue chip stocks to buy under $100. Blue chip stocks have long been considered the gold ...